FDA Announces Availability of Draft Guidance for Stability Testing of New Veterinary Drugs in Climatic Zones III and IV

Summary

The US Food and Drug Administration (FDA) has released a draft guidance document (GFI #259) for the stability testing of new veterinary drugs in regions with climatic zones III and IV, developed by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH).